Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Identification of in vivo components and exploration of the mechanism of action of Qishen Yiqi Dripping Pills based on UPLC-Q-TOF-MS/MS
Hits 240  Download times 57  Received:January 05, 2026  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2026.06.11
Key Words   Qishen Yiqi Dripping Pills;UPLC-Q-TOF-MS/MS;in vivo component identification;myocardial energy metabolism
Author NameAffiliationE-mail
LI Bin Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
DU Kunze Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, National Key Laboratory of Modern Chinese Medicine Creation, Tianjin 301617, China  
YANG Man Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHANG Qian Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Shuo Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, National Key Laboratory of Modern Chinese Medicine Creation, Tianjin 301617, China  
WANG Yanguo Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China  
LIU Yijia Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China lyj1204566353@163.com 
REN Ming Baokang Hospital Affiliated to Tianjin University of Traditional Chinese Medicine, Tianjin 300073, China renming2008@126.com 
Abstract
    [Objective] This study employed ultra- performance liquid chromatography coupled with quadrupole time- of-flight mass spectrometry(UPLC-Q-TOF-MS/MS)to systematically identify the absorbed constituents of Qishen Yiqi Dripping Pills(QSYQ)in rat serum and myocardial tissue,and to elucidate the potential cardioprotective mechanisms through energy metabolism-related signaling pathways. [Methods] UPLC-Q-TOF-MS/MS was used to analyze serum and myocardial tissue samples from rats administered QSYQ. The chemical structures of the detected compounds were confirmed through high-resolution natural product databases and literature comparison. Based on recent literature on myocardial energy metabolism,the study explored the energy-regulating effects of the absorbed constituents,focusing on pathways related to energy substrate utilization,mitochondrial function,purine cycling,and redox homeostasis. [Results] A total of 12 compounds were identified in serum and 9 in myocardial tissue,primarily including 11 amino acids,2 fatty acids,3 phenolic acids,1 flavonoid,2 purine derivatives,1 amide,and 1 heptane. [Conclusion] QSYQ may exert its cardioprotective effects through a“multi-component,multi-pathway,and multi-target”synergistic regulation of key energy metabolism networks,such as AMPK-mTOR-SIRT1,AMPK-Nrf2-PINK1/Parkin,TCA anaplerosis,and Nrf2-NF-κB pathways,thereby improving myocardial energy imbalance. This provides experimental evidence supporting the material basis for its pharmacological effects.

You are the 4277809 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.